Clinic
Options in Reproductive Care, INC.
Options in Reproductive Care, INC. was paid $846K by Medicaid between Jan 2018 and Aug 2019, across 25 billing codes. Its largest line is H1010, Non-medical family planning education, per session — 34% of everything it billed.
33Billing provider infoOPTIONS IN REPRODUCTIVE CARE, INC.
LA CROSSE, WI 54603
LA CROSSE, WI 54603
33aNPI1326086976assigned 06/04/2006
33bProvider typeNon-Surgical Family Planning Clinic/Center
28Total paid$846K
24GClaims26,448
24DCodes billed25
24AFirst – last monthJan 2018 – Aug 2019
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,321 | $539K | |
| 2019 | 9,127 | $307K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H1010 | Non-medical family planning education, per session | 34% | 6,025 | 5,592 | $290K |
| S4993 | Contraceptive pills for birth control | 26% | 3,022 | 2,741 | $222K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.0% | 2,133 | 1,997 | $60K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.6% | 1,161 | 1,117 | $39K |
| A4267 | Contraceptive supply, condom, male, each | 3.4% | 2,814 | 2,659 | $29K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3.4% | 70 | 69 | $29K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.9% | 917 | 881 | $25K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.4% | 1,782 | 1,741 | $20K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 2.3% | 336 | 324 | $20K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 432 | 409 | $19K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 2.1% | 57 | 57 | $18K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.4% | 218 | 207 | $12K |
13 more codes
| 99000 | 1.1% | 2,730 | $9K | |
| 87806 | 1.1% | 389 | $9K | |
| 84703 | 1.0% | 1,030 | $9K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 456 | $8K |
| 58300 | <1% | 211 | $7K | |
| 86703 | <1% | 348 | $6K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 480 | $4K |
| 87210 | <1% | 689 | $4K | |
| 11981 | <1% | 41 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 997 | $3K |
| 11982 | <1% | 18 | $1K | |
| J3490 | Unclassified drugs | <1% | 49 | $264.06 |
| 81002 | <1% | 43 | $135.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUSCH, JANET (EXECUTIVE DIRECTOR)